Prevalence of HTLV-I Tax in a subset of patients with rheumatoid arthritis

Clinical and Experimental Rheumatology

Volumn 20, Issue 2, 2002, Pages 161-170

  Zucker Franklin, D ^a   Pancake, B A ^a   Brown, W H ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HTLV I Tax; Rheumatoid arthritis

Indexed keywords

GAG PROTEIN; GENE PRODUCT; PROTEIN ANTIBODY; PROTEIN P40; RECOMBINANT PROTEIN; STRUCTURAL PROTEIN; TAX PROTEIN; VIRUS ENVELOPE PROTEIN;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; BLOOD DONOR; BLOOD SAMPLING; CELL ASSAY; CELL LYSATE; CONTROLLED STUDY; DATA ANALYSIS; ENDEMIC DISEASE; GENE SEQUENCE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; LYMPHOCYTE; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SERODIAGNOSIS; SEROLOGY; SOUTHERN BLOTTING; TRANSGENIC MOUSE; UNITED STATES; VIRUS CARRIER; VIRUS GENE; WESTERN BLOTTING; BLOOD; COMPARATIVE STUDY; DNA SEQUENCE; GENETICS; HUMAN T CELL LEUKEMIA VIRUS 2; IMMUNOLOGY; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; REFERENCE VALUE; VIROLOGY;

ARTHRITIS, RHEUMATOID; BASE SEQUENCE; GENE PRODUCTS, TAX; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PREVALENCE; REFERENCE VALUES; SEQUENCE ANALYSIS, DNA; UNITED STATES;

EID: 0036491055     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Human T-cell lymphotropic virus Type I (HTLV-I) tax among American blood donors
2. Rheumatic manifestations of human leukemia virus infection
3. HTLV-I arthropathy and Sjögren's syndrome
4. Arthritis syndromes associated with HTLV-I infection
5. High seroprevalence of anti-HTLV-I antibody in rheumatoid arthritis
6. Relative prevalence and risk factors of HTLV-I and HTLV-II infection in U.S. blood donors
7. Seroprevalence and epidemiological correlates of HTLV-I infection in U.S. blood donors
8. HTLV-I-induced T-cell activation
9. Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection
10. The molecular biology of human T-cell leukemia viruses
11. Extracellular human T cell leukemia virus type I tax protein stimulates the proliferation of human synovial cells
12. Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I
13. Auto-immunity induction by human T cell leukemia virus type I in transgenic mice that develop chronic inflammatory arthropathy resembling rheumatoid arthritis in humans
14. The human T cell leukemia virus type I tax gene is responsible for the development of both inflammatory polyarthropathy resembling rheumatoid arthritis and noninflammatory ankylotic arthropathy in transgenic mice
15. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
16. Ultrastructural, immunologic, and functional studies on Ségary cells: A neoplastic variant of thymus-derived (T) lymphocytes
17. The cutaneous T cell lymphoma, mycosis fungoides, is a human T cell lymphotrophic virus-associated disease. A study of 50 patients
18. Characterization of a sequence of the human T cell leukemia virus type-I from a patient with chronic progressive myelopathy
19. Re-examination of human T cell lymphotropic virus (HTLV-I/II) prevalence
20. Deleted HTLV-I provirus in blood and cutaneous lesions of patients with mycosis fungoides
21. Isolation and transmission of human retrovirus (human T-cell leukemia virus)
22. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T cell variant of hairy cell leukemia
23. Human adult T-cell leukemia virus: Complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA
24. Complete nucleotide sequence of an infectious clone of HTLV-II: An open reading frame for the protease gene
25. Complete nucleotide sequence of HTLV-II isolate NRA. Comparison of envelope sequence variation of HTLV-II isolates from U.S. blood donors and U.S. and Italian IV drug users
26. Multiple isolates and characteristics of human T-cell leukemia virus type II
27. Identification and characterization of a new and distinct molecular subtype of HTLV-II
28. Demonstration of antibodies to HTLV-I Tax in patients with the cutaneous T cell lymphoma, mycosis fungoides, who are seronegative for antibodies to the structural proteins of the virus
29. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase
30. Abundant synthesis of functional human T-cell leukemia virus type I p40x protein in eukaryotic cells by using a baculovirus expression vector
31. HTLV-I provirus in seronegative healthy blood donors
32. Molecular mimicry and immune-mediated diseases
33. The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune diseases
34. Mechanisms of viral pathogenesis in rheumatic disease
35. Multiple false-positive serologic tests for HIV, HTLV-I and hepatitis C following influenza vaccination
36. Detection of anti-HTLV-I Tax antibodies in HTLV-I enzyme-linked immunoassay-negative individuals
37. Polymerase chain reaction analysis of defective human T-cell leukemia virus Type I proviral genomes in leukemic cells of patients with adult T-cell leukemia
38. Defective provirus form of human T cell leukemia virus Type I in adult T-cell leukemia-/lymphoma: Clinicopathological features
39. Spastic paraparesis in a patient carrying defective human T cell leukemia virus type I (HTLV-I) provirus sequences but lacking a humoral or cytotoxic T cell response to HTLV-I
40. Hypopigmented mycosis fungoides associated with human T cell lymphotropic virus type I tax in a pediatric patient
41. Overgrowth of human synovial cells driven by the human T cell leukemia virus type I tax gene
42. Exocrinopathy resembling Sjögren's syndrome in HTLV-I tax transgenic mice
43. Localization of HTLV-I Tax in the nuclei of mononuclear leukocytes of healthy HTLV-I/II seronegative individuals
44. The difficulty of detecting HTLV-proviral sequences in patients with MF
45. Epstein-Barr virus-derived plasmids replicate once per cell cycle and are not amplified after entry into cells
46. Replication control of autonomously replicating human sequences
47. Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy
48. Infectious agents in the pathogenesis of rheumatoid arthritis
49. Potential infectious agents in the induction of arthritides
50. Epstein-Barr virus. Its relationship to the pathogenesis of rheumatoid arthritis
51. Is there a role for Epstein-Barr virus in the aetiology of rheumatoid arthritis?
52. Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro
53. In vitro effects of Epstein-Barr virus on peripheral blood mononuclear cells from patients with rheumatoid arthritis and normal subjects
54. Molecular mechanism of immune response, synovial proliferation and apoptosis in rheumatoid arthritis
55. T cell clonality in synovial fluid of a patient with rheumatoid arthritis: Persistent but fluctuant oligoclonal T cell expansions
56. High frequencies of identical T cell clonotypes in synovial tissues of rheumatoid arthritis patients suggest the occurrence of common antigen-driven immune responses
57. Involvement of the hypothalamic-pituitary/gonadal axis and the peripheral nervous system in rheumatoid arthritis